Correlation between hepatocyte growth factor receptor and vascular endothelial growth factor-A in breast carcinoma. 2010

Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
Department of Oncology, Wroclaw Medical University, Poland. gisti@op.pl

The aim of the study was to evaluate the prognostic value of the vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor receptor (HGFR, c-met) expressions in homogenous group of breast cancer patients. Tumor samples were collected from 98 patients with invasive ductal breast carcinoma stage II treated with primary surgery. We have observed a strong correlation between VEGF-A and c-met. No correlations were found between VEGF-A or HGFR expressions and clinical parameters (tumor size, grade, axillary lymph node status, age), 5- and 10-years DFS or OS. Our study did not reveal any prognostic value of c-met or VEGF. In addition they are not useful to separate a patients' subgroup with poor prognosis. Unlike in other authors' studies, our patients' group is very homogenous which might tribute to obtained results.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular

Related Publications

Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
January 2013, International journal of breast cancer,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
May 2006, Expert opinion on therapeutic patents,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
November 2002, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
June 2002, Virchows Archiv : an international journal of pathology,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
July 1999, Laboratory investigation; a journal of technical methods and pathology,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
August 2012, Vascular pharmacology,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
July 2007, The Journal of clinical endocrinology and metabolism,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
August 2010, Biochimica et biophysica acta,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
May 2002, Zhonghua yi xue za zhi,
Iwona Gisterek, and Rafał Matkowski, and Elzbieta Suder, and Agnieszka Hałoń, and Jolanta Szelachowska, and Ewelina Łata, and Aleksandra Łacko, and Przemysław Biecek, and Jan Kornafel
February 2004, Cancer letters,
Copied contents to your clipboard!